Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydr oxyethyl)-4-methylbenzamide

Details for Australian Patent Application No. 2005293290 (hide)

Owner Pharmacia & Upjohn Company LLC

Inventors Selbo, Jon G.

Agent Shelston IP

Pub. Number AU-A-2005293290

PCT Pub. Number WO2006/040649

Priority 60/618,466 13.10.04 US

Filing date 3 October 2005

Wipo publication date 20 April 2006

International Classifications

C07D 239/52 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Event Publications

5 April 2007 PCT application entered the National Phase

  PCT publication WO2006/040649 Priority application(s): WO2006/040649

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293293-Process for the preparation of N- (3,5-dichloropyrid-4-yl)-4difluoromethox y8-methanesulfonamido-dibenzo[b,d]fura n-1-carboxamide

2005293288-Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use